Logo image of VEEV

VEEVA SYSTEMS INC-CLASS A (VEEV) Stock Fundamental Analysis

NYSE:VEEV - New York Stock Exchange, Inc. - US9224751084 - Common Stock

223.04  +6.45 (+2.98%)

After market: 223.04 0 (0%)

Fundamental Rating

7

Taking everything into account, VEEV scores 7 out of 10 in our fundamental rating. VEEV was compared to 39 industry peers in the Health Care Technology industry. VEEV has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. VEEV is growing strongly while it is still valued neutral. This is a good combination! These ratings could make VEEV a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

VEEV had positive earnings in the past year.
VEEV had a positive operating cash flow in the past year.
Each year in the past 5 years VEEV has been profitable.
In the past 5 years VEEV always reported a positive cash flow from operatings.
VEEV Yearly Net Income VS EBIT VS OCF VS FCFVEEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

The Return On Assets of VEEV (10.32%) is better than 94.59% of its industry peers.
With an excellent Return On Equity value of 12.10%, VEEV belongs to the best of the industry, outperforming 94.59% of the companies in the same industry.
VEEV has a Return On Invested Capital of 9.08%. This is amongst the best in the industry. VEEV outperforms 97.30% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for VEEV is above the industry average of 6.36%.
Industry RankSector Rank
ROA 10.32%
ROE 12.1%
ROIC 9.08%
ROA(3y)10.08%
ROA(5y)11.19%
ROE(3y)13.04%
ROE(5y)14.79%
ROIC(3y)10.05%
ROIC(5y)11.22%
VEEV Yearly ROA, ROE, ROICVEEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of VEEV (25.07%) is better than 94.59% of its industry peers.
VEEV's Profit Margin has declined in the last couple of years.
The Operating Margin of VEEV (24.22%) is better than 97.30% of its industry peers.
VEEV's Operating Margin has declined in the last couple of years.
VEEV has a better Gross Margin (73.93%) than 81.08% of its industry peers.
In the last couple of years the Gross Margin of VEEV has remained more or less at the same level.
Industry RankSector Rank
OM 24.22%
PM (TTM) 25.07%
GM 73.93%
OM growth 3Y-11.02%
OM growth 5Y-6.82%
PM growth 3Y-5%
PM growth 5Y-3.55%
GM growth 3Y-0.34%
GM growth 5Y-0.06%
VEEV Yearly Profit, Operating, Gross MarginsVEEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), VEEV is creating some value.
The number of shares outstanding for VEEV has been increased compared to 1 year ago.
VEEV has more shares outstanding than it did 5 years ago.
There is no outstanding debt for VEEV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VEEV Yearly Shares OutstandingVEEV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
VEEV Yearly Total Debt VS Total AssetsVEEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 25.14 indicates that VEEV is not in any danger for bankruptcy at the moment.
VEEV has a Altman-Z score of 25.14. This is amongst the best in the industry. VEEV outperforms 94.59% of its industry peers.
VEEV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 25.14
ROIC/WACC0.95
WACC9.52%
VEEV Yearly LT Debt VS Equity VS FCFVEEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

VEEV has a Current Ratio of 6.36. This indicates that VEEV is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 6.36, VEEV belongs to the top of the industry, outperforming 97.30% of the companies in the same industry.
A Quick Ratio of 6.36 indicates that VEEV has no problem at all paying its short term obligations.
VEEV's Quick ratio of 6.36 is amongst the best of the industry. VEEV outperforms 97.30% of its industry peers.
Industry RankSector Rank
Current Ratio 6.36
Quick Ratio 6.36
VEEV Yearly Current Assets VS Current LiabilitesVEEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.57% over the past year.
Measured over the past years, VEEV shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.47% on average per year.
The Revenue has grown by 15.67% in the past year. This is quite good.
Measured over the past years, VEEV shows a very strong growth in Revenue. The Revenue has been growing by 22.35% on average per year.
EPS 1Y (TTM)35.57%
EPS 3Y18.08%
EPS 5Y24.47%
EPS Q2Q%30.6%
Revenue 1Y (TTM)15.67%
Revenue growth 3Y17.28%
Revenue growth 5Y22.35%
Sales Q2Q%13.42%

3.2 Future

Based on estimates for the next years, VEEV will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.50% on average per year.
Based on estimates for the next years, VEEV will show a quite strong growth in Revenue. The Revenue will grow by 13.40% on average per year.
EPS Next Y34.73%
EPS Next 2Y20.68%
EPS Next 3Y17.45%
EPS Next 5Y16.5%
Revenue Next Year15.74%
Revenue Next 2Y13.94%
Revenue Next 3Y13.53%
Revenue Next 5Y13.4%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
VEEV Yearly Revenue VS EstimatesVEEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
VEEV Yearly EPS VS EstimatesVEEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 35.69, VEEV can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of VEEV indicates a rather cheap valuation: VEEV is cheaper than 83.78% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.29. VEEV is valued slightly more expensive when compared to this.
Based on the Price/Forward Earnings ratio of 31.64, the valuation of VEEV can be described as expensive.
78.38% of the companies in the same industry are more expensive than VEEV, based on the Price/Forward Earnings ratio.
VEEV's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 24.44.
Industry RankSector Rank
PE 35.69
Fwd PE 31.64
VEEV Price Earnings VS Forward Price EarningsVEEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, VEEV is valued a bit cheaper than 70.27% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, VEEV is valued a bit cheaper than the industry average as 67.57% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 34.33
EV/EBITDA 39.82
VEEV Per share dataVEEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
VEEV has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as VEEV's earnings are expected to grow with 17.45% in the coming years.
PEG (NY)1.03
PEG (5Y)1.46
EPS Next 2Y20.68%
EPS Next 3Y17.45%

More info and screens

0

5. Dividend

5.1 Amount

VEEV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VEEVA SYSTEMS INC-CLASS A

NYSE:VEEV (1/21/2025, 8:04:00 PM)

After market: 223.04 0 (0%)

223.04

+6.45 (+2.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)12-05 2024-12-05/amc
Earnings (Next)N/A N/A
Inst Owners83.6%
Inst Owner Change0.34%
Ins Owners8.85%
Ins Owner Change0.03%
Market Cap36.21B
Analysts78.42
Price Target273.43 (22.59%)
Short Float %1.83%
Short Ratio2.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.06%
Min EPS beat(2)3.51%
Max EPS beat(2)8.6%
EPS beat(4)4
Avg EPS beat(4)4.86%
Min EPS beat(4)3.17%
Max EPS beat(4)8.6%
EPS beat(8)8
Avg EPS beat(8)5.83%
EPS beat(12)11
Avg EPS beat(12)4.64%
EPS beat(16)15
Avg EPS beat(16)6.1%
Revenue beat(2)1
Avg Revenue beat(2)-0.36%
Min Revenue beat(2)-0.82%
Max Revenue beat(2)0.09%
Revenue beat(4)1
Avg Revenue beat(4)-0.47%
Min Revenue beat(4)-0.82%
Max Revenue beat(4)0.09%
Revenue beat(8)2
Avg Revenue beat(8)-0.65%
Revenue beat(12)2
Avg Revenue beat(12)-0.63%
Revenue beat(16)5
Avg Revenue beat(16)-0.16%
PT rev (1m)7.58%
PT rev (3m)15.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.57%
EPS NY rev (1m)0%
EPS NY rev (3m)2.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.62%
Valuation
Industry RankSector Rank
PE 35.69
Fwd PE 31.64
P/S 13.63
P/FCF 34.33
P/OCF 33.58
P/B 6.58
P/tB 7.22
EV/EBITDA 39.82
EPS(TTM)6.25
EY2.8%
EPS(NY)7.05
Fwd EY3.16%
FCF(TTM)6.5
FCFY2.91%
OCF(TTM)6.64
OCFY2.98%
SpS16.36
BVpS33.89
TBVpS30.88
PEG (NY)1.03
PEG (5Y)1.46
Profitability
Industry RankSector Rank
ROA 10.32%
ROE 12.1%
ROCE 11.5%
ROIC 9.08%
ROICexc 95.37%
ROICexgc 1142.97%
OM 24.22%
PM (TTM) 25.07%
GM 73.93%
FCFM 39.71%
ROA(3y)10.08%
ROA(5y)11.19%
ROE(3y)13.04%
ROE(5y)14.79%
ROIC(3y)10.05%
ROIC(5y)11.22%
ROICexc(3y)55.65%
ROICexc(5y)49.48%
ROICexgc(3y)356.57%
ROICexgc(5y)339.82%
ROCE(3y)12.72%
ROCE(5y)14.2%
ROICexcg growth 3Y-13.2%
ROICexcg growth 5Y-16.56%
ROICexc growth 3Y2.45%
ROICexc growth 5Y-14.96%
OM growth 3Y-11.02%
OM growth 5Y-6.82%
PM growth 3Y-5%
PM growth 5Y-3.55%
GM growth 3Y-0.34%
GM growth 5Y-0.06%
F-Score6
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 61.8%
Cap/Sales 0.89%
Interest Coverage 250
Cash Conversion 158.26%
Profit Quality 158.39%
Current Ratio 6.36
Quick Ratio 6.36
Altman-Z 25.14
F-Score6
WACC9.52%
ROIC/WACC0.95
Cap/Depr(3y)59.5%
Cap/Depr(5y)45.92%
Cap/Sales(3y)0.83%
Cap/Sales(5y)0.7%
Profit Quality(3y)167.06%
Profit Quality(5y)157.56%
High Growth Momentum
Growth
EPS 1Y (TTM)35.57%
EPS 3Y18.08%
EPS 5Y24.47%
EPS Q2Q%30.6%
EPS Next Y34.73%
EPS Next 2Y20.68%
EPS Next 3Y17.45%
EPS Next 5Y16.5%
Revenue 1Y (TTM)15.67%
Revenue growth 3Y17.28%
Revenue growth 5Y22.35%
Sales Q2Q%13.42%
Revenue Next Year15.74%
Revenue Next 2Y13.94%
Revenue Next 3Y13.53%
Revenue Next 5Y13.4%
EBIT growth 1Y59.67%
EBIT growth 3Y4.35%
EBIT growth 5Y14.01%
EBIT Next Year37.82%
EBIT Next 3Y19.86%
EBIT Next 5Y19.7%
FCF growth 1Y39.2%
FCF growth 3Y17.73%
FCF growth 5Y24.08%
OCF growth 1Y39.82%
OCF growth 3Y18.25%
OCF growth 5Y24.01%